Carcinogenesis Advance Access originally published online on March 26, 2007
Carcinogenesis 2007 28(7):1510-1519; doi:10.1093/carcin/bgm062
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Twenty-four non-synonymous polymorphisms in the one-carbon metabolic pathway and risk of colorectal adenoma in the Nurses' Health Study
1 Program in Molecular and Genetic Epidemiology, Department of Epidemiology
2 Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA
3 Department of Biostatistics, Harvard School of Public Health, Boston, MA 02115, USA
4 Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA
5 Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA
* To whom correspondence should be addressed. Tel: +1 617 525 2035; Fax: +1 617 525 2008; Email: ahazra{at}hsph.harvard.edu
Dietary folate and alcohol consumption as well as polymorphic variants in one-carbon metabolism genes may modulate risk of colorectal adenoma through aberrant DNA methylation and altered nucleotide synthesis and repair. We assessed the association of 24 non-synonymous single nucleotide polymorphisms (nsSNPs) in 13 genes in the one-carbon metabolism pathway and risk of colorectal adenoma in 556 incident cases and 557 controls nested in the Nurses' Health Study. Most of the SNPs were not associated with risk of colorectal adenoma. We did, however, observe a modest increased risk among carriers of the transcobalamin (TCN) II 259 Pro/Arg + Arg/Arg variant (odds ratio 1.48, 95% confidence interval 1.09–2.02) for colorectal adenoma. The TCN II Pro259Arg polymorphism may affect TCN binding and transport of vitamin B12 and thus warrants further investigation of its biological function. In addition, the methionine synthase reductase (MTRR) Arg415Cys and MTRR Ser284Thr variant carriers, also in the vitamin B12 pathway, have suggestive associations with advanced colorectal adenoma (defined as being larger than 1 cm, villous, tubular–villous or carcinoma in situ histology). We observed significant evidence for departure from multiplicative interaction for the betaine–homocysteine methyltransferase (BHMT) Arg239Gln with dietary methyl status (based on intake of dietary folate, methionine and alcohol intake) in relation to colorectal adenoma; no such interaction was observed for the other 23 SNPs. Further investigation is required to validate the association of the polymorphisms in the one-carbon metabolic genes and risk of colorectal adenoma.
Abbreviations: BHMT, betaine–homocysteine methyltransferase; CI, confidence interval; FOLH, Folate hydrolase; FTHFD, formyltetrahydrofolate dehydrogenase; MTHFD1, methylenetetrahydrofolate dehydrogenase; MTHFR, methylenetetrahydrofoloate reductase; MTHFS, methylenetetrahydrofolate synthase; MTRR, methionine synthase reductase; NHS, Nurses' Health Study; nsSNP, non-synonymous single nucleotide polymorphism; OR, odds ratio; SNPs, single nucleotide polymorphisms; TCN, transcobalamin II
Received December 5, 2006; revised March 6, 2007; accepted March 10, 2007.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. de Vogel, K. A.D. Wouters, R. W.H. Gottschalk, F. J. van Schooten, A. F.P.M. de Goeij, A. P. de Bruine, R. A. Goldbohm, P. A. van den Brandt, M. P. Weijenberg, and M. van Engeland Genetic Variants of Methyl Metabolizing Enzymes and Epigenetic Regulators: Associations with Promoter CpG Island Hypermethylation in Colorectal Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2009; 18(11): 3086 - 3096. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yamaji, M. Iwasaki, S. Sasazuki, H. Sakamoto, T. Yoshida, and S. Tsugane Methionine Synthase A2756G Polymorphism Interacts with Alcohol and Folate Intake to Influence the Risk of Colorectal Adenoma Cancer Epidemiol. Biomarkers Prev., January 1, 2009; 18(1): 267 - 274. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Figueiredo, A. J. Levine, M. V. Grau, O. Midttun, P. M. Ueland, D. J. Ahnen, E. L. Barry, S. Tsang, D. Munroe, I. Ali, et al. Vitamins B2, B6, and B12 and Risk of New Colorectal Adenomas in a Randomized Trial of Aspirin Use and Folic Acid Supplementation Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 2136 - 2145. [Abstract] [Full Text] [PDF]
|
|